Account
Ranbaxy Laboratories Ltd. has stopped production of its generic version of cholesterol-lowering drug Lipitor as the company investigates what caused tiny glass particles to appear in some bottles, triggering a large recall earlier this month.Details also emerged Thursday of a smaller recall of Ranbaxy's generic Lipitor in August, over a potential pill mix-up.The U.S. Food and Drug Administration, which disclosed Ranbaxy's production halt Thursday, said it didn't anticipate a shortage of atorvastatin—the generic name for Lipitor—because there are other manufacturers. The FDA said it is monitoring the situation and is working with other manufacturers to ensure adequate supply.The FDA and Ranbaxy said they weren't aware of any adverse health problems resulting from the presence of glass particles in the company's atorvastatin product. Ranbaxy is an Indian unit of Japan's Daiichi Sankyo Co.Ranbaxy said it voluntarily recalled 41 lots of atorvastatin on Nov. 9 because some batches contained...
Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into dozens of batches of t...
Consumer Reports prescription drugs editor Lisa Gill on the reasons why prescription drugs have dropped in cost this year.
It may take a breakthrough treatment for Alzheimer's disease to match the $130 billion lifetime sales record of Pfizer's Lipitor, the cholesterol fighter that wrote ...
Pfizer Inc. on Wednesday declined to comment on reports it hopes to start marketing an over-the-counter version of its cholesterol drug Lipitor, the world's biggest-...
FBN's Ashley Webster breaks down Pfizer's plan for generic version of Lipitor .
Anna Kooiman with top medical stories
The European Union has approved a new chewable form of cholesterol blockbuster Lipitor for children 10 and up with high levels of bad cholesterol and triglycerides, ...
FOX News medical advisor Dr. Marc Siegel discusses the impact of the expiration of Lipitor's patent.
Pfizer is recalling a lot of 19,000 bottles of the blockbuster cholesterol drug Lipitor, citing a consumer complaint about an "uncharacteristic" odor.The latest anno...
A federal judge Friday upheld the validity of two key U.S. patents on Pfizer Inc.'s ( PFE ) Lipitor cholesterol drug, blocking a generic version of the medicine that...
Pfizer said Monday it is pulling its Lipitor advertisements that feature the inventor of the artificial heart whose endorsement came under congressional fire earlier...
Some of the most popular prescription drugs that recently became available in generic form are sold at the lowest prices at Costco and at the highest prices at CVS C...
Ranbaxy Laboratories Ltd. has recalled more than 40 lots of its generic version of the cholesterol-lowering drug Lipitor from the U.S. market after finding batches c...
No one wants to spend more money on medications. In fact, people under 65 are twice as likely as older Americans to skip their meds, according to a new Centers for D...
Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at lea...
Five big U.S. retailers filed an antitrust lawsuit against Pfizer Inc and India's Ranbaxy Laboratories Ltd on Thursday, accusing them of conspiring to delay sales of...
The cholesterol-lowering agent red yeast rice, an alternative treatment method for patients that can't tolerate statin drugs, doesn't work any better when a plant-de...
Some 8.7 million Americans take Lipitor for high cholesterol. Starting Wednesday, they might get a different-looking pill when they go to fill a prescription and pay...
The U.S. Food and Drug Administration confirmed on Wednesday that it had given approval to Ranbaxy Laboratories Ltd to make the first generic version of the choleste...